U.S. Markets closed

Free Research Report as Aetna’s Quarterly EPS Soared 89.7%

Stock Monitor: Anthem Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 08, 2018 / Active-Investors.com has just released a free earnings report on Aetna Inc. (NYSE: AET). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=AET. The Company reported its fourth quarter fiscal 2017 and full fiscal year 2017 operating and financial results on January 30, 2018. The Health Insurer outperformed top- and bottom-line expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Anthem, Inc. (NYSE: ANTM), which also belongs to the Healthcare sector as the Company Aetna. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=ANTM

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Aetna most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=AET

Earnings Highlights and Summary

For Q4 2017, Aetna's total revenues and adjusted revenues were $14.9 billion and $14.7 billion, respectively, and were each at $15.7 billion for Q4 2016. The decrease in total revenues and adjusted revenues was primarily attributed to lower premiums in Aetna's Health Care segment, as well as the sale of Aetna's domestic group life insurance, group disability insurance, and absence management businesses (Group Insurance sale) on November 01, 2017. The Company's total revenue numbers exceeded analysts' expectations of $14.8 billion.

For the full-year FY17, Aetna's total revenues and adjusted revenues were $60.5 billion and $60.7 billion, respectively, compared to $63.2 billion and $63.0 billion, respectively, for FY16.

For Q4 2017, Aetna's effective tax rate was 51.7% compared to 53.5% for Q4 2016. The Company's effective tax rate was 36.3% for FY17 compared to 43.5% for FY16. Aetna's Q4 2017 and FY17 results each included an incremental tax expense of $99 million related to the estimated reduction in net deferred tax assets as a result of the enactment of the Tax Cuts and Jobs Act of 2017 (TCJA) in December 2017. Excluding the impact of the TCJA, the effective tax rate was 32.9% and 33.0% for Q4 2017 and FY17, respectively.

Aetna's net income was $244 million, or $0.74 per diluted share, in Q4 2017 compared to a net income of $139 million, or $0.39 per diluted share, in Q4 2016. The increase in earnings was primarily due to lower restructuring, transaction, and integration-related costs in FY17 compared to FY16. Aetna's adjusted earnings were $411 million, or $1.25 per share, for the reported quarter compared to $578 million, or $1.63 per share, for the year earlier same quarter. The Company's earnings beat Wall Street's estimates of $1.20 per share.

Aetna's net income was $1.9 billion, or $5.68 per share, for FY17 compared to $2.3 billion, or $6.41 per share, for FY16. The Company's adjusted earnings were $3.3 billion, or $9.86 per share, for FY17 compared to $2.9 billion, or $8.23 per share, for FY16.

Segment Results

During Q4 2017, Aetna's Health Care segment's total revenues were $14.5 billion compared to $15.0 billion for Q4 2016. The segment's adjusted revenues were $14.4 billion for the reported quarter versus $15.0 billion for the year earlier comparable quarter.

For Q4 2017, the Health Care segment's income before income taxes was $587 million compared to $905 million for Q4 2016. The segment's pre-tax adjusted earnings were $662 million in the reported quarter compared to $964 million in the year earlier corresponding quarter. The segment's days claims payable was 49 days at December 31, 2017; a decrease of five days compared to December 31, 2016.

During Q4 2017, Aetna's Group Insurance segment's total revenues were $324 million and $620 million for Q4 2017 and Q4 2016, respectively. The segment's adjusted revenues were $237 million and $621 million for Q4 2017 and Q4 2016, respectively. The decrease in total revenues and adjusted revenues were primarily due to the Group Insurance sale.

Aetna's Group Insurance segment's income before income taxes was $103 million for Q4 2017 compared to $36 million for Q4 2016. The segment's pre-tax adjusted earnings were $16 million for the reported quarter compared to $37 million for the year earlier same quarter.

Aetna's Large Case Pensions segment's total revenues were $74 million and $64 million for Q4 2017 and Q4 2016, respectively. The segment's adjusted revenues were $71 million in the reported quarter versus $64 million in the year earlier comparable quarter. The increase in total revenues and adjusted revenues was primarily due to higher premiums in Q4 2017.

The Large Case Pensions segment's income before income taxes was $6 million in Q4 2017 compared to $3 million for Q4 2016. The segment's pre-tax adjusted earnings were each $3 million for Q4 2017 and Q4 2016.

Cash Matters

Aetna's total debt to consolidated capitalization ratio was 37.0% at December 31, 2017, compared to 53.6% at December 31, 2016. The Company's Health Care and Group Insurance cash flows used for operations were approximately $178 million during FY17.

Aetna's cash and investments at the parent were approximately $2.2 billion at December 31, 2017. Net subsidiary dividends to the parent, including the proceeds received from the Group Insurance sale, were $2.1 billion in the reported quarter. During Q4 2017, Aetna repaid $1.0 billion in debt and paid a shareholder dividend of $163 million. After other sources and uses, Aetna ended Q4 2017 with approximately $2.2 billion of cash and investments at the parent.

Suspended Share Repurchase

On December 03, 2017, Aetna and CVS Health Corp. announced a definitive merger agreement under which CVS Health will acquire all of the outstanding shares of Aetna. The transaction is expected to close in H2 2018. As a result of the pending CVS Health transaction, Aetna has suspended repurchases of its common shares.

Stock Performance Snapshot

February 07, 2018 - At Wednesday's closing bell, Aetna's stock slightly dropped 0.29%, ending the trading session at $181.49.

Volume traded for the day: 2.11 million shares.

Stock performance in the last three-month – up 2.57%; previous six-month period – up 16.14%; past twelve-month period – up 50.40%; and year-to-date – up 0.61%

After yesterday's close, Aetna's market cap was at $59.95 billion.

Price to Earnings (P/E) ratio was at 31.54.

The stock has a dividend yield of 1.10%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors